Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,853 | -90,210 | -60,345 | -50,158 | -40,571 |
| Depreciation Amortization | 896 | 881 | 1,113 | 1,391 | 431 |
| Income taxes - deferred | 23 | 141 | 392 | 219 | 693 |
| Accounts payable and accrued liabilities | -367 | 1,149 | -722 | 1,727 | -1,146 |
| Other Working Capital | 4,381 | 1,475 | -1,037 | -1,425 | 5,060 |
| Other Operating Activity | 13,904 | 19,174 | 11,490 | 6,419 | 5,724 |
| Operating Cash Flow | $-70,016 | $-67,390 | $-49,109 | $-41,827 | $-29,809 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,368 | -37,935 | -21,997 | -119,356 | 7,277 |
| PPE Investments | -42 | -52 | -275 | -340 | -584 |
| Investing Cash Flow | $-12,410 | $-37,987 | $-22,272 | $-119,696 | $6,693 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 16,876 |
| Debt Issued | N/A | N/A | N/A | 149,080 | 0 |
| Debt Repayment | N/A | N/A | N/A | -12,880 | 0 |
| Common Stock Issued | 164,383 | 42,295 | 167,496 | 914 | 120 |
| Other Financing Activity | -388 | -344 | -401 | -2,721 | 68,519 |
| Financing Cash Flow | $163,995 | $41,951 | $167,095 | $134,393 | $85,515 |
| Exchange Rate Effect | -56 | 117 | -178 | -25 | 80 |
| Beginning Cash Position | 79,926 | 143,235 | 47,699 | 74,854 | 12,375 |
| End Cash Position | 161,439 | 79,926 | 143,235 | 47,699 | 74,854 |
| Net Cash Flow | $81,513 | $-63,309 | $95,536 | $-27,155 | $62,479 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,016 | -67,390 | -49,109 | -41,827 | -29,809 |
| Capital Expenditure | -42 | -52 | -275 | -340 | -584 |
| Free Cash Flow | -70,058 | -67,442 | -49,384 | -42,167 | -30,393 |